Capnia Inc (NASDAQ:CAPN) was downgraded by equities researchers at Maxim Group from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday.

Shares of Capnia (NASDAQ:CAPN) traded up 3.09% on Wednesday, hitting $1.00. The company had a trading volume of 10,187 shares. The firm’s 50 day moving average price is $0.97 and its 200-day moving average price is $1.06. The stock’s market capitalization is $15.76 million. Capnia has a 52 week low of $0.80 and a 52 week high of $2.20.

TRADEMARK VIOLATION WARNING: This piece of content was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be accessed at

About Capnia

Capnia, Inc is a healthcare company that develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company also has a therapeutics platform based on its technology for precision metering of gas flow. Its first commercial product, CoSense End-Tidal Carbon Monoxide (ETCO) Monitor, aids in the detection of excessive hemolysis, a condition in which red blood cells degrade rapidly.

5 Day Chart for NASDAQ:CAPN

Receive News & Stock Ratings for Capnia Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc and related stocks with our FREE daily email newsletter.